Patients with atopic dermatitis who are on Janus kinase inhibitors did not show an increased risk for venous thromboembolism, according to a study. “Previous meta-analyses of several immune-mediated inflammatory diseases, such as psoriasis, rheumatoid arthritis, and inflammatory bowel disease, have found no significant increased risk of [venous thromboembolism (VTE)] in patients receiving